BTSG insider trade: 235,000 shares sold at $28.782; holdings updated

Rhea-AI Filing Summary

BrightSpring Health Services (BTSG) reported an insider transaction by its Chairman, President and CEO. On October 22, 2025, the reporting person exercised 235,000 stock options at $6.37 and sold 235,000 common shares at $28.782 pursuant to a registered public offering.

Following the transactions, direct ownership stands at 1,131,930 common shares. The filing also lists 369,763 shares held indirectly by the Rousseau Family Trust. Remaining option holdings include 560,241 options (direct) and indirect options of 534,676 (by The Margaret Rousseau Children Trust) and 377,602 (by the Rousseau Family Trust), each with a $6.37 exercise price and 10/16/2029 expiration. The options are noted as fully vested.

Insider Trade Summary

Exercise and Sale: 235,000 shares ($5.27M approx. pre-tax spread)

Exercise and Sale 6 txns

Insider ROUSSEAU JON B

Role See Remarks

Sold 235,000 shs ($6.76M)

Approx. gross sale proceeds $6.76M

Approx. exercise cost $1.50M

Approx. pre-tax spread $5.27M

Type	Security	Shares	Price	Value
Exercise	Stock Options (Right to Buy)	235,000	$0.00	$0.00
Exercise	Common Stock	235,000	$6.37	$1.50M
Sale	Common Stock	235,000	$28.782	$6.76M
holding	Stock Options (Right to Buy)	--	--	--
holding	Stock Options (Right to Buy)	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Options (Right to Buy) — 560,241 shares (Direct); Common Stock — 1,131,930 shares (Direct); Stock Options (Right to Buy) — 534,676 shares (Indirect, By The Margaret Rousseau Children Trust); Stock Options (Right to Buy) — 377,602 shares (Indirect, By Rousseau Family Trust); Common Stock — 369,763 shares (Indirect, By Rousseau Family Trust)

Footnotes (3)

1. F1. These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on October 22, 2025, at a price of $28.7820.
2. F2. The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein.
3. F3. These options are fully vested.

FAQ

What did BTSG's CEO do in the latest Form 4?

Exercised 235,000 options at $6.37 and sold 235,000 shares at $28.782 on October 22, 2025 in a registered public offering.

How many BTSG shares does the reporting person hold after the transactions?

Holds 1,131,930 common shares directly and 369,763 shares indirectly via the Rousseau Family Trust.

What stock options remain for the BTSG reporting person?

Remaining options include 560,241 (direct), plus 534,676 and 377,602 held indirectly by named trusts; exercise price $6.37, expiration 10/16/2029.

At what price were the BTSG shares sold?

Shares were sold at $28.782 per share pursuant to a registered public offering that closed on October 22, 2025.

Are the BTSG options vested?

Yes. The filing states the options are fully vested.

What is the issuer in this Form 4 and its ticker?

The issuer is BrightSpring Health Services, Inc. with ticker BTSG.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 10/22/2025 - 04:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROUSSEAU JON B

(Last) (First) (Middle)

C/O BRIGHTSPRING HEALTH SERVICES, INC.

805 N. WHITTINGTON PARKWAY

(Street)

LOUISVILLE KY 40222

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BrightSpring Health Services, Inc. [ BTSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
10/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/22/2025		M		235,000	A	$6.37	1,366,930	D
Common Stock	10/22/2025		S(1)		235,000	D	$28.782(1)	1,131,930	D
Common Stock								369,763	I	By Rousseau Family Trust(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$6.37	10/22/2025		M			235,000	(3)	10/16/2029	Common Stock	235,000	$0	560,241	D
Stock Options (Right to Buy)	$6.37							(3)	10/16/2029	Common Stock	534,676		534,676	I	By The Margaret Rousseau Children Trust(2)
Stock Options (Right to Buy)	$6.37							(3)	10/16/2029	Common Stock	377,602		377,602	I	By Rousseau Family Trust(2)

Explanation of Responses:

1. These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on October 22, 2025, at a price of $28.7820.

2. The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein.

3. These options are fully vested.

Remarks:

Title: Chairman, President and Chief Executive Officer

	/s/ Jennifer Phipps, as Attorney-in-Fact	10/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.